Estun’s 1H26E shows a strong recovery from a low base, but A-share valuation fully reflects optimistic humanoid robot expectations
AI summary card
Estun’s 1H26E shows a strong recovery from a low base, but A-share valuation fully reflects optimistic humanoid robot expectations
Deutsche Bank expects Estun’s 1H26E profit to grow sharply year on year. A potential acquisition of Codroid would make a limited short-term financial contribution but could support valuation sentiment; A-share Sell reiterated, H-share coverage initiated with Hold.
- 2Q26E sales are expected to reach RMB1.5bn, up 15% year on year, with net profit of RMB40mn, a significant improvement from the 2Q25 loss.
- 1H26E sales are expected to reach RMB2.7bn, up 7% year on year, with net profit of RMB138mn, up approximately 1960%, mainly driven by the low base.
- 2026E revenue is forecast at RMB6bn, net profit at RMB305mn, and net margin at 5.1%, broadly in line with company guidance.
- Codroid recorded 2025 revenue of RMB50.2mn and a net loss of RMB53mn. Its short-term financial contribution is expected to be limited, but its humanoid robot exposure has improved market sentiment.
- The A-share target price was raised from RMB20 to RMB31.4, but Sell was reiterated; H-share coverage was initiated with Hold and a target price of HK$23.6.
Report interpretation
Overview
This report provides Deutsche Bank’s earnings preview for Estun Automation and initiates coverage of its H shares. It focuses on earnings recovery in 2Q26 and 1H26, the humanoid robot theme catalyst from a potential acquisition of Codroid, and the valuation gap between A and H shares. The analyst expects short-term market sentiment to continue supporting the share price, but sees weaker 12-month risk/reward for A shares and a more balanced profile for H shares.
Core views
The core views are: first, Estun’s 1H26E net profit is expected to grow strongly from a very low base, and the company may issue a positive earnings preannouncement in July; second, the 2026E revenue and net margin forecasts are consistent with company guidance, with earnings improvement driven by sales recovery, the realization of price increases, and expense control; third, a potential Codroid acquisition would make a limited near-term contribution to revenue and profit, but its humanoid robot exposure could improve valuation sentiment; fourth, A-share 2026E P/S is approximately 7.4x and 2026E/2027E P/E is approximately 146x/98x, indicating a fairly full valuation; fifth, H-share 2026E P/S is approximately 3.3x and 2026E/2027E P/E is approximately 64x/43x, with the valuation discount resulting in a more balanced risk/reward profile.
Analysis framework
The report applies an earnings forecast, peer valuation comparison, A/H discount analysis, and a three-stage DCF valuation framework. For the A-share target price, the report raises its medium-term growth assumptions to reflect the opportunity in embodied-AI robots; for the H-share target price, it applies a 35% discount to the A-share target price, close to the average H-share discount among approximately 50 dual-listed companies tracked by Deutsche Bank since 2H24.
Methodology notes
Derive the target price using detailed forecasts for 2026-2028, medium-term assumptions, and the terminal growth rate.
The report uses a 3.5% terminal growth rate, a 1.8% risk-free rate, a 5% equity risk premium, and a 1.61 beta, deriving a 9.3% WACC.
The H-share target price is based on the A-share target price with a discount applied.
The report applies a 35% discount to the A-share target price for the H-share target price as the H-share valuation benchmark, referencing the average discount among dual-listed companies.
The impact of humanoid robot exposure on valuation and market sentiment.
The report believes Codroid’s short-term financial contribution will be limited, but its humanoid robot exposure could increase market attention to Estun and improve valuation sentiment.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Estun A shares 002747.SZCore covered security
- Strengths
- A leading position in China’s industrial robot market, with strong expected earnings recovery in 2026E and an embodied-AI robot opportunity that raises medium-term growth assumptions.
- Weaknesses
- High A-share valuation, with 2026E P/S of approximately 7.4x and 2026E/2027E P/E of approximately 146x/98x.
- Comparison
- Compared with humanoid robot peer UBTECH’s 2026E P/S of 11x, Estun has lower humanoid robot exposure; compared with its own long-term one-year forward P/E of 67.5x, current valuation is high.
- Risks
- A-share valuation could come under pressure if robot demand slows, pricing pressure returns, or the humanoid robot business makes a limited contribution.
- Estun H shares 2715.HKNewly covered security
- Strengths
- Lower H-share valuation, with 2026E P/S of approximately 3.3x and a significant discount to A shares, resulting in a more balanced risk/reward profile.
- Weaknesses
- The Hong Kong market is more conservative toward the humanoid robot opportunity, and related companies’ H shares trade at an average discount of more than 50%.
- Comparison
- The report derives the H-share target price by applying a 35% discount to the A-share target price, close to the average H-share discount among dual-listed companies since 2H24.
- Risks
- It faces the same risks related to robot demand, pricing pressure, humanoid robot commercialization, and geopolitics.
- CodroidPotential acquisition target and source of theme catalyst
- Strengths
- It has businesses in collaborative robots, embodied robots, and core components, and has launched embodied robot products including Codroid 02, C05-U, and C05-L.
- Weaknesses
- Its 2025 revenue scale was small and it was loss-making, with revenue of RMB50.2mn and a net loss of RMB53mn.
- Comparison
- Relative to Estun group’s 2026E revenue of RMB6bn, its short-term financial contribution is expected to be small.
- Risks
- Theme-based valuation support could weaken if commercialization progresses slowly or model training costs increase.
Key data
- 2Q26E salesRMB1.5bn, up 15% year on yearSales growth would improve significantly from -2% in 1Q26.
- 2Q26E net profitRMB40mnAn improvement from the RMB-6mn loss in 2Q25, but below RMB98mn in 1Q26.
- 1H26E salesRMB2.7bn, up 7% year on yearRevenue is expected to return to growth in the first half.
- 1H26E net profitRMB138mn, up 1960% year on yearThe sharp year-on-year increase is mainly attributable to the low base in 1H25.
- 2026E revenue and net profitRevenue RMB6.0bn; net profit RMB305mn; net margin 5.1%Broadly in line with the company’s guidance of RMB6bn revenue and a 5% net margin.
- Codroid 2025 financialsRevenue RMB50.2mn; net loss RMB53mnThe report expects the potential acquisition to make a limited short-term financial contribution.
- A-share valuation2026E P/S 7.4x; 2026E/2027E P/E 146x/98xAbove the long-term one-year forward P/E of 67.5x.
- H-share valuation2026E P/S 3.3x; 2026E/2027E P/E 64x/43xA substantial discount to A shares, resulting in a more balanced risk/reward profile.
- A-share target priceRMB31.4Raised from RMB20, while the rating remains Sell.
- H-share target priceHK$23.6Hold initiated with coverage.
Impact & implications
In the short term, the earnings preannouncement, profit recovery from a low base, and the humanoid robot theme may continue to support Estun’s share price, particularly its A shares. Over the medium to long term, the report believes A-share valuation already reflects optimistic expectations, and upside would be limited unless the humanoid robot business makes a substantial contribution to group revenue and profit; H shares offer a more balanced risk/reward profile due to their larger valuation discount.
Risks
- Deterioration in robot market demand accompanied by renewed pricing pressure.
- Limited sales contribution from humanoid robots alongside rising model training costs.
- Increasing geopolitical risks weighing on Estun’s overseas sales.
- A-share valuation is already fairly full, creating potential downside if earnings fall short of expectations.
- 2Q26E net profit is expected to be lower sequentially than 1Q26 because 1Q26 included RMB87mn in non-recurring gains.
- The collection cycle for auto-related sales receivables is relatively long, and asset impairment may increase sequentially.
What to watch
- Whether Estun issues a positive earnings preannouncement in July 2026.
- The complete 1H26 results scheduled for disclosure on the evening of August 21, 2026.
- Whether 2Q26E sales growth is supported jointly by battery and electronics end-market demand, the realization of 1Q26 price increases, and the low base.
- Transaction terms, closing progress, and consolidation impact of the potential all-cash acquisition of Codroid.
- Whether the humanoid robot business begins to make a substantial contribution to group revenue and profit.
- Whether the discount between A and H shares continues to widen or narrows.
- Demand, market-share changes, and pricing competition in China’s and Europe’s industrial robot markets.